Dechema visits Berlin-Buch: Trading in cells - Lab cultures, patients, and the promise of applications

Cell therapies carry high dreams and expectations with them, based on a simple idea: to optimize the body’s own resources to eradicate diseases. Some are already available on the market, for instance to treat articular cartilage defect and to treat damaged corneas with limbal stem cells. But most of them are still in an early stage of development or in clinical trials – to treat cancer, heart failure, diabetes or prevent transplant rejection. The market size of the successful ones is expected to grow rapidly in the near future.

This year, the symposium “DECHEMA visits Berlin-Buch” will highlight the latest developments in the field of cell therapies.
Two international key notes, Steven A. Goldman from the University of Rochester, US, and Michele De Luca from the University of Modena, Italy, will present their work on stem cells for the therapy of neurodegenerative diseases and skin regeneration respectively. Further experts from industry and academia will present their current projects and challenges.

A poster session in the afternoon break and a get-together in the evening will provide plenty of time for networking.

More information and registration here:
18.10.2017 13:00 - 18:00
Registrierung erforderlich
The colloquium is organised by Berlin Partner for Business and Technology GmbH, Campus Berlin-Buch, and supported by DECHEMA e.V.

MDC.C Axon 2
Max Delbrück Communications Center
Robert-Rössle-Str. 10
Berlin Germany

Annett Krause
BBB Management GmbH Campus Berlin-Buch

fon030 9489 2920


Annett Krause
Event Website